Mar 28 |
Syros Pharmaceuticals, Inc. (NASDAQ:SYRS) Q4 2023 Earnings Call Transcript
|
Mar 28 |
Syros Pharmaceuticals Full Year 2023 Earnings: Misses Expectations
|
Mar 27 |
Syros Pharmaceuticals, Inc. (SYRS) Q4 2023 Earnings Call Transcript
|
Mar 27 |
Syros Pharmaceuticals GAAP EPS of -$2.18 misses by $1.04, revenue of $0.4M misses by $1.6M
|
Mar 27 |
Syros Reports Fourth Quarter and Full Year 2023 Financial Results and Provides a Corporate Update
|
Mar 27 |
Earnings Scheduled For March 27, 2024
|
Mar 26 |
Syros Pharmaceuticals Q4 2023 Earnings Preview
|
Mar 25 |
Syros Announces Completion of Enrollment of 190 Patients Necessary to Support Primary Endpoint Analysis in SELECT-MDS-1 Phase 3 Trial
|
Mar 20 |
Syros to Report Fourth Quarter and Full Year 2023 Financial Results on Wednesday, March 27, 2024
|
Feb 27 |
Syros to Participate in TD Cowen 44th Annual Health Care Conference
|